Fisher & Paykel have been well known in New Zealand for years, but are now assessing how to become more profitable.
Deutsche Bank have been brought in to advise on options for the future, as rumours circulate that Fisher & Paykel will spin off their highly successful healthcare business (which produces humidifiers and incubators).
"What we've asked Deutsche Bank to do is to work with us to realise long-term shareholder value," said Fisher & Paykel managing director Gary Paykel.
Fisher & Paykel posted a $NZ54.4 million profit last financial year, with the healthcare division growing by 21%, while the whitegoods division was seen to grow only 6.2%.
This result was about $3-4 million above expectations according to Cavill White, head of John Cairns research.
"It's a very solid result, underwritten by continual growth in healthcare and an excellent contribution from whiteware," White continued.
Paykel went on to say there were a few options up Fisher & Paykel's sleeve, but declined to elaborate on them.